Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.24 USD | -4.62% |
|
+14.81% | +5.98% |
Jun. 25 | Oppenheimer Initiates Clearside Biomedical at Outperform With $5 Price Target | MT |
May. 13 | HC Wainwright Adjusts Price Target on Clearside Biomedical to $5 From $6, Keeps Buy Rating | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+5.98% | 92.67M | |
+15.82% | 122B | |
+20.35% | 114B | |
+18.31% | 25.71B | |
-25.31% | 19.02B | |
-20.84% | 15.83B | |
-19.67% | 15.32B | |
-46.87% | 14.88B | |
+62.55% | 14.82B | |
+6.34% | 14.1B |
- Stock Market
- Equities
- CLSD Stock
- News Clearside Biomedical, Inc.
- Transcript : Clearside Biomedical, Inc. Presents at JP Morgan 37th Annual Healthcare conference, Jan-10-2019 08